Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
51 results
  1. Meta-analysis & network meta-analysis results - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536506
    ... months) MMSE (12 months) – sensitivity analysis excluding rofecoxib ADCS-ADL (12 months) ADCS-ADL (12 months) – sensitivity analysis excluding rofecoxib ADCS-ADL, ...
  2. Key Question 4: Efficacy and Harms of Supplements Versus Placebo for Cognition, Function, and Quality of Life - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556544
    ... to Moderate NR ADAS-cog (11-item) NR ADCS-ADL NR CDR, Sum of Boxes NR Omega-3 ... Mild to Moderate AD MMSE ADAS-Cog NR ADCS-ADL NR CDR, Sum of Boxes NR TOTAL 10 ...
  3. Key Question 3: Efficacy and Harms of Prescription Drug Treatment Versus Placebo for Cognition, Function, and Quality ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556554
    ... 54 Cognitive Tests ADAS-Cog MMSE SIB Function ADCS-ADL DAD IDDD Global Impression of Change GDS CGIC ... Placebo 24 weeks Cognitive Tests ADAS-Cog Function ADCS-ADL Harms SAEs Withdrawal due to AE All-cause ...
  4. Detailed Trial Results for Trials of AChEIs and Memantine - Screening for Cognitive Impairment in Older Adults: An ... 
    https://www.ncbi.nlm.nih.gov/books/NBK554653
    ... Galantamine Auchus, 2007 204 Fair Dem ADL/IADL (ADCS-ADL, 0–78, ↑) IG1 6 48.3 (17.2) ‡ ... Brodaty, 2005 205 Fair-Good Dem ADL/IADL (ADCS-ADL, 0–78, ↑) IG1 3 52.0 (0.90) ...
  5. Detailed Trial Results for Trials of Other Medications and Supplements - Screening for Cognitive Impairment in Older ... 
    https://www.ncbi.nlm.nih.gov/books/NBK554645
    ... inhibitor Simvastatin Sano, 2011 239 Fair Dem ADL (ADCS-ADL, 0–27, ↓) IG1 3 67.2 (10.0) ... NS HMG-CoA reductase inhibitor Simvastatin Dem ADL (ADCS-ADL, 0–27, ↓) IG1 6 67.2 (10.0) ...
  6. Health Economics - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536504
    ... s Disease Cooperative Study - Activities of Daily Living [ADCS-ADL] scale). The ADCS-ADL is a multi-item instrument used to assess ... or the need for assistance. Scores on the ADCS-ADL range from 0 to 78, with higher scores ...
  7. Detailed Trial Results for Trials of Patient-Level Nonpharmacologic Interventions - Screening for Cognitive Impairment .... 
    https://www.ncbi.nlm.nih.gov/books/NBK554659
    ... NS Orrell, 2014 * 281 Good Dem ADL/IADL (ADCS-ADL, 0–78, ↑) IG1 3 42.7 (17.2) ... 08, 5.20), 0.04 Dem ADL/IADL (ADCS-ADL, 0–78, ↑) IG1 6 42.7 (17.2) ... NS Hoffmann, 2016 * 304 Good Dem ADL/IADL (ADCS-ADL, 0–78, ↑) IG1 4 64.8 (8.8) ...
  8. Cholinesterase inhibitors and memantine for dementia - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536484
    ... verbal fluency (VFT) and activities of daily living (ADCS-ADL/BADLS) were significantly improved in people treated with ... cognition (ADAS-cog; MMSE), activities of daily living (ADCS-ADL/BADLS), global functioning (CIBIC plus), behavioural and psychological ...
  9. Key Question 5: Comparative Effectiveness and Harms of Prescription Drug Treatment Versus Other Active Treatments for ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556560
    ... ADAS-Cog= Alzheimer’s Disease Assessment Scale-Cog; ADCS-ADL=Alzheimer’s Disease Cooperative Study-Activities of Daily ... ADAS-Cog= Alzheimer’s Disease Assessment Scale-Cog; ADCS-ADL=Alzheimer’s Disease Cooperative Study-Activities of Daily ...
  10. Pharmacological management of dementia associated with Parkinson’s disease - Parkinson’s disease in adults: diagnosis ... 
    https://www.ncbi.nlm.nih.gov/books/NBK535864
    ... rivastigmine capsules at 24 weeks, as assessed by ADCS-ADL, but there was a significant benefit for rivastigmine ... living between memantine and placebo, as assessed by ADCS-ADL (MD=0.80, 95%CI −3.22 to ...
first · previous · 1 · 2 · 3 · 4 · 5 · next · last